Spotting these signs early is important
In a phase 2 clinical study, patients who were administered 20 mg/day lorcaserin attained an average weight loss of 3.6 kg, which was significantly greater than the average weight loss of 0.3 kg in the placebo group [82]
The compounds research profile now spans adipose tissue biology, skeletal muscle physiology, gut microbiome modulation, cardiovascular metabolic pathways, and cancer cell biology
When a compound has no completed human trial, there is by definition no safety data in any subgroup no pregnancy data, no hepatic-impairment data, no interaction data with common metabolic or endocrine medications
If youre on the fence, consider your day-to-day: Do you deal with fatigue that doesnt match your sleep, recurring brain fog, or a pattern of good day, crash day
For those with a personal or family history of diabetes, high blood pressure, blood vessel disease, or high blood sugar, semaglutide treatment should always be monitored by a qualified medical professional
